Related Experiment Video
Updated: Jul 15, 2026

14:14
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
Assessing the direct effects of deep brain stimulation using embedded axon models.
Stamatios N Sotiropoulos1, Peter N Steinmetz
1Brain Modeling Laboratory, Harrington Department of Bioengineering, Mail Code 9709, ASU Main Campus, Tempe, AZ 85287, USA. soti0003@umn.edu
Journal of Neural Engineering
|April 6, 2007
Summary
Deep brain stimulation (DBS) can activate neurons up to 4 mm away from the target, affecting areas beyond the subthalamic nucleus (STN). This suggests that other brain regions contribute to DBS therapeutic effects in Parkinson's disease.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Computational Biology
Background:
- Deep brain stimulation (DBS) is a key therapy for Parkinson's disease.
- Understanding the precise spread of electrical stimulation in the brain is crucial for optimizing DBS efficacy.
- Previous models lacked detailed anatomical and electrical property considerations.
Purpose of the Study:
- To model the spatial extent of direct neuronal activation by DBS.
- To investigate the influence of brain tissue properties on electrical field spread.
- To identify brain regions activated by DBS targeting the subthalamic nucleus (STN).
Main Methods:
- Developed a geometrically realistic finite element electrical model.
- Incorporated anisotropic and inhomogeneous tissue conductivities.
- Utilized multi-compartment axon models with anatomically consistent geometry and orientation.
Main Results:
- Simulations showed axonal activation up to 4 mm from the stimulated STN.
- Activation occurred in the fields of Forel (FF), internal capsule (IC), substantia nigra (SN), and zona incerta (ZI).
- Sensitivity analysis confirmed consistent activation in FF and IC.
Conclusions:
- Direct axonal activation outside the STN occurs with typical DBS parameters.
- The spread of activation into surrounding white matter tracts (IC, FF) and nuclei (SN, ZI) is significant.
- These findings suggest that non-target brain regions contribute to the therapeutic benefits of DBS for Parkinsonian symptoms.
